CanSino Biologics
(SEHK) 6185
CanSino Biologics Financials at a Glance
Market Cap
HK$6.38B
Revenue (TTM)
CN¥1.11B
Net Income (TTM)
-CN¥848.43K
EPS (TTM)
-HK$0.01
P/E Ratio
-2582.00
Dividend
HK$0.00
Beta (Volatility)
0.05 (Low)
Dividend
HK$0.00
Beta (Volatility)
0.05 (Low)
Price
HK$25.82
Volume
1,462,800
Open
HK$25.78
Price
HK$25.82
Volume
1,462,800
Open
HK$25.78
Previous Close
HK$25.46
Daily Range
HK$24.88 - HK$26.30
52-Week Range
HK$24.88 - HK$56.55
Dividend
HK$0.00
Beta (Volatility)
0.05 (Low)
Price
HK$25.82
Volume
1,462,800
Open
HK$25.78
Previous Close
HK$25.46
Daily Range
HK$24.88 - HK$26.30
52-Week Range
HK$24.88 - HK$56.55
6185 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CanSino Biologics
Industry
Biotechnology
Sector
Health CareEmployees
1,134
CEO
Xue Feng Yu, PhD
Website
www.cansinotech.comHeadquarters
Tianjin, 300457, CN
6185 Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-0%
Net Income Margin
-0%
Return on Equity
-5%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
-0.04%
Dividend Yield
0.00%
Payout Ratio
-23.46%
Stock Overview
Market Cap
HK$6.38B
Shares Outstanding
247.04M
Volume
1.46M
Avg. Volume
990.90K
Financials (TTM)
Gross Profit
CN¥681.82M
Operating Income
-CN¥113.12M
EBITDA
CN¥60.98M
Operating Cash Flow
CN¥32.49M
Capital Expenditure
-CN¥185.32M
Free Cash Flow
-CN¥152.83M
Cash & ST Invst.
CN¥2.65B
Total Debt
CN¥1.29B
CanSino Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥188.56M
+37.5%
Gross Profit
CN¥152.63M
+34.6%
Gross Margin
80.94%
N/A
Market Cap
HK$6.38B
N/A
Market Cap/Employee
HK$5.77M
N/A
Employees
1,105
N/A
Net Income
-CN¥40.06M
-247.0%
EBITDA
-CN¥41.77M
-249.4%
Quarterly Fundamentals
Net Cash
CN¥916.65M
-17.0%
Accounts Receivable
CN¥818.04M
+22.8%
Inventory
CN¥399.75M
+23.9%
Long Term Debt
CN¥949.51M
-15.7%
Short Term Debt
CN¥208.36M
-75.7%
Return on Assets
-0.01%
N/A
Return on Invested Capital
-0.03%
N/A
Free Cash Flow
-CN¥88.54M
-9.1%
Operating Cash Flow
-CN¥57.74M
-318.3%